Sera Q2 revenue $123K, net loss $10.5M; appoints interim CEO and CFO

SERA PROGNOSTICS, INC.

2023-Q2 EPS reported -$0.68 revenue$223,000

Revenue $123,000 (Q2 2023) vs $78,000 (Q2 2022), up 58% YoY but still minimal.
Net loss $10.5M vs $11.5M; operating expenses $11.6M vs $11.8M.
Cash, equivalents, and securities $92.1M as of June 30, 2023.
Appointed Zhenya Lindgardt interim President/CEO and Austin Aerts interim CFO; headcount reductions in commercial team.
Engaged strategy firm to evaluate paths to enhance revenue at reduced cost for PreTRM Test commercialization.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SERA PROGNOSTICS, INC. reported the second quarter ended June 30, 2023 results: revenue $123,000, net income $10.5 million.

Period: the second quarter ended June 30, 2023
Revenue: $123,000
Net income: $10.5 million
Result: reported results

Exact text from the filing

our role as a leader in health diagnostics to improve the lives of women and babies through prenatal care.” Second Quarter 2023 Financial Results Second quarter 2023 revenue of $123,000 compared to $78,000 for the same period of 2022. Total operating expenses were $11.6 million, down from $11.8 million for the second quarter of 2022. Research and development

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

SERA PROGNOSTICS, INC. filing history →

Source: SEC EDGAR

accession 0001534969-23-000091

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.